Collplant Biotechnologies Ltd ADR (CLGN) Stock Price, Quote & News

Company Profile

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on its recombinant human collagen (rhCollagen) that is produced using its proprietary technology. The company offers regenerative dermal and soft tissue fillers; 3D-bioprinted regenerative breast implants; Collage, a combinant human Collag...

Industry: Biotechnology

Sector: Healthcare

Phone: 972 73 232 5600

Fax: 972 73 232 5602

Website: collplant.com

Address:

Weizmann Science Park, 4 Oppenheimer P.O. Box 4132, Rehovot, Israel

focafoca99 Aug. 19 at 2:12 AM

$CLGN approved two shareholder proposals at its extraordinary meeting.

0 · Reply

Zephix Aug. 9 at 8:33 PM

$CLGN Exploring new strategic collaborations….

0 · Reply

Zephix Aug. 9 at 8:30 PM

$CLGN Multiple medical aesthetics & regenerative medicine programs🩺

0 · Reply

STACKD0E Aug. 6 at 3:48 PM

$CLGN 👁️

0 · Reply

green_going_up Aug. 2 at 7:38 PM

$CLGN thousands of firms to acquire in the medical aesthetics industry. Stop waiting and ACT!!! Hire an I-Banking firm that knows this market well. Do M&A, NOW!!!

0 · Reply

dln101 Jul. 31 at 6:47 PM

$MGRX which bio penny gonna be next to 🚀 $AZTR or $CLGN 🤔💪📈

0 · Reply

green_going_up Jul. 31 at 12:54 AM

$CLGN firm needs to pivot and do M&A; it just did a similar raise a few months ago. This is not sustainable.

0 · Reply

focafoca99 Jul. 1 at 1:09 PM

$CLGN offered a private placement of ~7.6M shares and warrants at $0.34 each, targeting $2.6M gross proceeds, closing around July 1.

0 · Reply

focafoca99 Jun. 30 at 12:27 PM

$CLGN issued a $2.6M private placement of shares and warrants at $0.34 per unit.

0 · Reply

dln101 Jun. 9 at 5:53 PM

$CLGN or $DFNS which one of these lower float pennies will come back from the dead first - like $PAVS $DSSI $ELPW 🤔💪🔥🚀

0 · Reply

CollPlant Biotechnologies Registration statement: Registration filing

2026-06-30T12:10:39.000Z - 7 weeks ago

CollPlant announces $2.6M private placement

Jun 30, 2026, 8:00 AM EDT - 7 weeks ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.6 MILLION PRIVATE PLACEMENT

May 29, 2026, 7:00 AM EDT - 2 months ago

COLLPLANT BIOTECHNOLOGIES REPORTS 2026 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

May 29, 2026, 7:00 AM EDT - 2 months ago

CollPlant Biotechnologies Earnings release: Q1 2026

Apr 15, 2026, 8:00 AM EDT - 4 months ago

CollPlant Biotechnologies Registration statement: Registration filing

Apr 13, 2026, 7:00 AM EDT - 4 months ago

CollPlant Issues Letter to Shareholders

2026-03-30T22:00:13.000Z - 5 months ago

CollPlant files to sell 3.3M ordinary shares for holders

Mar 30, 2026, 8:00 AM EDT - 5 months ago

CollPlant Biotechnologies Registration statement: Registration filing

Mar 26, 2026, 9:30 AM EDT - 5 months ago

CollPlant Biotechnologies Earnings release: Q4 2025

Mar 26, 2026, 9:30 AM EDT - 5 months ago

CollPlant Biotechnologies Annual report: Q4 2025

Mar 26, 2026, 8:30 AM EDT - 5 months ago

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

2026-03-24T20:05:57.000Z - 5 months ago

CollPlant receives non-compliance letter from Nasdaq

Mar 24, 2026, 4:01 PM EDT - 5 months ago

CollPlant Biotechnologies Receives Nasdaq Notification Regarding Minimum Bid Requirement

Mar 18, 2026, 9:00 AM EDT - 5 months ago

CollPlant Biotechnologies Launches Redesigned Corporate Website

Mar 11, 2026, 8:00 AM EDT - 5 months ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTS

2026-02-26T13:38:42.000Z - 6 months ago

CollPlant granted Korean patent for photocurable dermal filler

Feb 26, 2026, 8:00 AM EST - 6 months ago

CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler

Feb 23, 2026, 7:00 AM EST - 6 months ago

CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex

Feb 17, 2026, 7:00 AM EST - 6 months ago

CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments

2026-02-06T13:07:03.000Z - 6 months ago

CollPlant downgraded to Hold from Buy at D. Boral Capital

2026-02-05T13:06:22.000Z - 6 months ago

CollPlant to sell 1.6M ordinary shares at $1.25 in registered direct offering

Feb 5, 2026, 8:00 AM EST - 6 months ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERING

Jan 26, 2026, 6:00 AM EST - 7 months ago

CollPlant Biotechnologies Slides: Corporate presentation

2026-01-09T21:20:23.000Z - 7 months ago

CollPlant files $100M mixed securities shelf

Jan 9, 2026, 7:00 AM EST - 7 months ago

CollPlant Biotechnologies Registration statement: Registration Filing

Nov 26, 2025, 9:30 AM EST - 9 months ago

CollPlant Biotechnologies Earnings release: Q3 2025

2025-11-26T12:41:24.000Z - 9 months ago

CollPlant to reduce workforce by 25%

ABBV

2025-11-26T12:35:52.000Z - 9 months ago

CollPlant reports Q3 non-GAAP EPS (25c) vs. (33c) last year

Nov 26, 2025, 7:30 AM EST - 9 months ago

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Nov 18, 2025, 7:00 AM EST - 9 months ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS

2025-10-27T11:16:21.000Z - 10 months ago

CollPlant expands rhCollagen capabilities in U.S., Canada

Oct 27, 2025, 7:01 AM EDT - 10 months ago

CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada

2025-10-20T11:05:45.000Z - 10 months ago

CollPlant’s Collink.3D shows strong performance vs. Matrigel in study

GLW

Oct 20, 2025, 7:00 AM EDT - 10 months ago

CollPlant's rhCollagen-Based BioInk Demonstrates Strong Performance Compared to Matrigel® in Study Conducted by Technion - Israel Institute of Technology

Oct 16, 2025, 7:00 AM EDT - 10 months ago

First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk

2025-09-30T12:33:59.000Z - 11 months ago

Why Is Collplant Stock (CLGN) Down 25% Today?

2025-09-30T11:10:49.000Z - 11 months ago

CollPlant’s dermal filler shows positive non-clinical results

Sep 30, 2025, 7:00 AM EDT - 11 months ago

CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler

2025-09-15T11:10:53.000Z - 1 year ago

CollPlant expands distribution of Vergenix STR product in Europe

Sep 15, 2025, 7:00 AM EDT - 1 year ago

CollPlant Expands the Distribution of its VergenixSTR Product in Europe

Sep 2, 2025, 7:00 AM EDT - 1 year ago

CollPlant to Present at the 2025 International Conference on Biofabrication

Aug 25, 2025, 7:00 AM EDT - 1 year ago

CollPlant to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference

Aug 20, 2025, 9:30 AM EDT - 1 year ago

CollPlant Biotechnologies Earnings release: Q2 2025

Aug 20, 2025, 7:00 AM EDT - 1 year ago

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Aug 5, 2025, 7:00 AM EDT - 1 year ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR SECOND QUARTER FINANCIAL RESULTS

Jul 14, 2025, 7:00 AM EDT - 1 year ago

CollPlant Appoints Collagen Biomaterials Expert as New Head of North America Commercial Operations

Jun 17, 2025, 8:00 AM EDT - 1 year ago

CollPlant Biotechnologies Registration statement: Registration Filing

2025-06-09T11:10:41.000Z - 1 year ago

CollPlant announces expansion of agreement with STEMCELL

Jun 9, 2025, 7:00 AM EDT - 1 year ago

COLLPLANT BROADENS ITS COLLABORATION WITH STEMCELL TECHNOLOGIES

Jun 4, 2025, 7:00 AM EDT - 1 year ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES EUROPEAN PATENT ALLOWANCE SECURED FOR ITS COLLAGEN-BASED FORMULATIONS USABLE AS SOFT TISSUE FILLERS AND IMPLANTS

May 30, 2025, 7:00 AM EDT - 1 year ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES $3.6 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES

May 28, 2025, 9:30 AM EDT - 1 year ago

CollPlant Biotechnologies Earnings release: Q1 2025

May 28, 2025, 7:00 AM EDT - 1 year ago

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE

May 14, 2025, 7:00 AM EDT - 1 year ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FIRST QUARTER FINANCIAL RESULTS

Apr 15, 2025, 8:00 AM EDT - 1 year ago

CollPlant's Collink.3D® BioInks and Technologies Offer a Relevant and Timely Solution to FDA's Plan to Reduce Animal Testing in Preclinical Safety Studies

Mar 26, 2025, 10:00 AM EDT - 1 year ago

CollPlant Biotechnologies Earnings Call Transcript: Q4 2024

Mar 26, 2025, 10:00 AM EDT - 1 year ago

CollPlant Biotechnologies Annual report: Q4 2024

Mar 26, 2025, 10:00 AM EDT - 1 year ago

CollPlant Biotechnologies Earnings release: Q4 2024

Mar 26, 2025, 8:00 AM EDT - 1 year ago

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE

SSYS

Mar 19, 2025, 7:00 AM EDT - 1 year ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Feb 24, 2025, 7:00 AM EST - 1 year ago

CollPlant Expands Distribution for its VergenixSTR Product in Europe and Asia

Feb 12, 2025, 7:00 AM EST - 1 year ago

CollPlant Biotechnologies Slides: Corporate Presentation

Feb 12, 2025, 6:00 AM EST - 1 year ago

CollPlant Biotechnologies Provides a Corporate Update

Nov 27, 2024, 10:00 AM EST - 1 year ago

CollPlant Biotechnologies Earnings Call Transcript: Q3 2024

Nov 27, 2024, 10:00 AM EST - 1 year ago

CollPlant Biotechnologies Earnings release: Q3 2024

Nov 27, 2024, 7:00 AM EST - 1 year ago

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

SSYS

Nov 12, 2024, 7:00 AM EST - 1 year ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Aug 20, 2024, 10:00 AM EDT - 2 years ago

CollPlant Biotechnologies Earnings Call Transcript: Q2 2024

Aug 20, 2024, 10:00 AM EDT - 2 years ago

CollPlant Biotechnologies Earnings release: Q2 2024

Aug 20, 2024, 7:00 AM EDT - 2 years ago

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

SSYS

Aug 19, 2024, 8:30 AM EDT - 2 years ago

CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants

SSYS

Aug 6, 2024, 7:00 AM EDT - 2 years ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 SECOND QUARTER FINANCIAL STATEMENTS AND CONFERENCE CALL INFORMATION

Jul 29, 2024, 7:00 AM EDT - 2 years ago

CollPlant Biotechnologies Unveils Inaugural ESG and Sustainability Report

Jun 6, 2024, 7:00 AM EDT - 2 years ago

CollPlant Successfully Bio-Prints 200cc Commercial-Size Regenerative Breast Implants and Reports Additional Positive Pre-Clinical Data

May 29, 2024, 7:00 AM EDT - 2 years ago

CollPlant Biotechnologies Announces First Quarter Financial Results For 2024 and Provides Corporate Update

May 29, 2024, 7:00 AM EDT - 2 years ago

CollPlant Biotechnologies Earnings release: Q1 2024

May 16, 2024, 7:00 AM EDT - 2 years ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Apr 4, 2024, 8:00 AM EDT - 2 years ago

CollPlant Biotechnologies Earnings Call Transcript: Q4 2023

Apr 4, 2024, 8:00 AM EDT - 2 years ago

CollPlant Biotechnologies Annual report: Q4 2023

Apr 4, 2024, 8:00 AM EDT - 2 years ago

CollPlant Biotechnologies Earnings release: Q4 2023

Apr 4, 2024, 7:17 AM EDT - 2 years ago

COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Mar 26, 2024, 8:00 AM EDT - 2 years ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Jan 8, 2024, 7:18 AM EST - 2 years ago

CollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California

Jan 2, 2024, 7:00 AM EST - 2 years ago

CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants

Nov 29, 2023, 8:00 AM EST - 2 years ago

CollPlant Biotechnologies Earnings Call Transcript: Q3 2023

Nov 29, 2023, 8:00 AM EST - 2 years ago

CollPlant Biotechnologies Earnings release: Q3 2023

Nov 29, 2023, 7:00 AM EST - 2 years ago

CollPlant Biotechnologies Announces Third Quarter Financial Results for 2023

Nov 9, 2023, 8:00 AM EST - 3 years ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Nov 1, 2023, 7:05 AM EDT - 3 years ago

CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal Filler

Sep 21, 2023, 7:00 AM EDT - 3 years ago

CollPlant Biotechnologies Joins the United Nations Global Compact, The World's Largest Corporate Sustainability Initiative

focafoca99 Aug. 19 at 2:12 AM

$CLGN approved two shareholder proposals at its extraordinary meeting.

0 · Reply

Zephix Aug. 9 at 8:33 PM

$CLGN Exploring new strategic collaborations….

0 · Reply

Zephix Aug. 9 at 8:30 PM

$CLGN Multiple medical aesthetics & regenerative medicine programs🩺

0 · Reply

STACKD0E Aug. 6 at 3:48 PM

$CLGN 👁️

0 · Reply

green_going_up Aug. 2 at 7:38 PM

$CLGN thousands of firms to acquire in the medical aesthetics industry. Stop waiting and ACT!!! Hire an I-Banking firm that knows this market well. Do M&A, NOW!!!

0 · Reply

dln101 Jul. 31 at 6:47 PM

$MGRX which bio penny gonna be next to 🚀 $AZTR or $CLGN 🤔💪📈

0 · Reply

green_going_up Jul. 31 at 12:54 AM

$CLGN firm needs to pivot and do M&A; it just did a similar raise a few months ago. This is not sustainable.

0 · Reply

focafoca99 Jul. 1 at 1:09 PM

$CLGN offered a private placement of ~7.6M shares and warrants at $0.34 each, targeting $2.6M gross proceeds, closing around July 1.

0 · Reply

focafoca99 Jun. 30 at 12:27 PM

$CLGN issued a $2.6M private placement of shares and warrants at $0.34 per unit.

0 · Reply

dln101 Jun. 9 at 5:53 PM

$CLGN or $DFNS which one of these lower float pennies will come back from the dead first - like $PAVS $DSSI $ELPW 🤔💪🔥🚀

0 · Reply

rapidtrades Jun. 1 at 2:21 PM

$CLGN JOINED AGAIN AT $0.39

0 · Reply

dln101 May. 27 at 7:59 PM

$CLGN should give a move like $CNEY 🤔💪📈

0 · Reply

SuperGreenToday May. 6 at 7:49 PM

$CLGN Share Price: $0.41 Contract Selected: Oct 16, 2026 $2.5 Calls Buy Zone: $0.04 – $0.05 Target Zone: $0.07 – $0.09 Potential Upside: 76% ROI Time to Expiration: 162 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

dln101 Apr. 30 at 6:23 PM

$CLGN low float penny trading thin bit of volume sends it.. lets clear 0.5 today and close gap towards $1 🤔 $OSRH style 💪🔥🚀

0 · Reply

dln101 Apr. 15 at 7:27 PM

$CLGN if it was good enough for Abbvie, matter of time another player snatches its ip up.. news send this like $BIRD or $IMMP 🤔💪🔥🚀

1 · Reply

dln101 Apr. 14 at 3:10 PM

$CLGN beaten down hard at these levels, no love whatsoever from buyers … rebound like peer $GLMD soon $RKTO style or 🕳️

1 · Reply

focafoca99 Apr. 13 at 3:32 PM

$CLGN told shareholders the AbbVie aesthetics deal is ending, but management is now trying to replace it with new partners while cutting costs.

0 · Reply

DARKP00L Apr. 13 at 11:22 AM

$CLGN 07:12 on Apr. 13 2026 CollPlant Biotechnologies Announces Termination Of Development Agreement With AbbVie, Issues Letter to Shareholders, Will Reduce Headcount By 50% #tradeideas

0 · Reply

dln101 Apr. 10 at 3:12 PM

$CLGN maybe next in line after peer $GLMD to give a spike to $ALDX levels 🤔💪🔥🚀 $CREG style

0 · Reply

dln101 Apr. 10 at 2:41 PM

$CLGN this thinly traded low floater penny can double to $CREG levels real quick 🤔💪🔥🚀

0 · Reply

dln101 Apr. 9 at 2:47 PM

$GLMD running out of steam 🤔 maybe next israeli low floater bio to spike 👉 $CLGN 💪📈

0 · Reply

Market Cap	4.62M
Revenue (ttm)	2.37M
Net Income (ttm)	-11.49M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-484.81%
Debt to Equity Ratio	0.00

Volume	72,300
Avg Vol	63,376
Day's Range	N/A - N/A
Shares Out	14.44M
Stochastic %K	50%
Beta	1.67
Analysts	Strong Sell
Price Target	$11.00